CL2012001759A1 - Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica. - Google Patents
Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.Info
- Publication number
- CL2012001759A1 CL2012001759A1 CL2012001759A CL2012001759A CL2012001759A1 CL 2012001759 A1 CL2012001759 A1 CL 2012001759A1 CL 2012001759 A CL2012001759 A CL 2012001759A CL 2012001759 A CL2012001759 A CL 2012001759A CL 2012001759 A1 CL2012001759 A1 CL 2012001759A1
- Authority
- CL
- Chile
- Prior art keywords
- hydroxyquinoline
- pharmaceutical composition
- derived compounds
- carboxamide
- carboxamide derived
- Prior art date
Links
- FOXMISVOVQTSGS-UHFFFAOYSA-N 8-hydroxyquinoline-7-carboxamide Chemical compound C1=CC=NC2=C(O)C(C(=O)N)=CC=C21 FOXMISVOVQTSGS-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; y formulación farmacéutica que los contiene.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09180895A EP2345641A1 (en) | 2009-12-29 | 2009-12-29 | New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012001759A1 true CL2012001759A1 (es) | 2012-12-07 |
Family
ID=42025709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012001759A CL2012001759A1 (es) | 2009-12-29 | 2012-06-26 | Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica. |
Country Status (38)
Country | Link |
---|---|
US (1) | US8729076B2 (es) |
EP (2) | EP2345641A1 (es) |
JP (1) | JP5755245B2 (es) |
KR (1) | KR20120097407A (es) |
CN (1) | CN102712596B (es) |
AU (1) | AU2010338269B2 (es) |
BR (1) | BR112012015732A2 (es) |
CA (1) | CA2783230A1 (es) |
CL (1) | CL2012001759A1 (es) |
CO (1) | CO6561775A2 (es) |
CY (1) | CY1115060T1 (es) |
DK (1) | DK2519504T3 (es) |
DO (1) | DOP2012000185A (es) |
EA (1) | EA020487B1 (es) |
EC (1) | ECSP12012008A (es) |
ES (1) | ES2460626T3 (es) |
GE (1) | GEP20156269B (es) |
GT (1) | GT201200214A (es) |
HK (1) | HK1178525A1 (es) |
HR (1) | HRP20140348T1 (es) |
IL (1) | IL220307A (es) |
MA (1) | MA33830B1 (es) |
ME (1) | ME01748B (es) |
MX (1) | MX2012007746A (es) |
MY (1) | MY162548A (es) |
NI (1) | NI201200115A (es) |
NZ (1) | NZ600782A (es) |
PE (1) | PE20121804A1 (es) |
PL (1) | PL2519504T3 (es) |
PT (1) | PT2519504E (es) |
RS (1) | RS53303B (es) |
SG (1) | SG181588A1 (es) |
SI (1) | SI2519504T1 (es) |
SM (1) | SMT201400059B (es) |
TN (1) | TN2012000319A1 (es) |
UA (1) | UA109422C2 (es) |
WO (1) | WO2011080266A1 (es) |
ZA (1) | ZA201204349B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2345642A1 (en) * | 2009-12-29 | 2011-07-20 | Polichem S.A. | Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
EP2345643A1 (en) * | 2009-12-29 | 2011-07-20 | Polichem S.A. | New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
CN104805147B (zh) * | 2014-01-26 | 2018-01-05 | 上海医药工业研究院 | 一种二噁英类化合物的制备方法、纯化方法及应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US326330A (en) | 1885-09-15 | Harness-support | ||
US326328A (en) | 1885-09-15 | Broiler | ||
DE540842C (de) | 1930-08-06 | 1931-12-28 | Chinosol Fabrik Akt Ges | Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure |
FR2160718A1 (en) * | 1971-11-23 | 1973-07-06 | Roussel Uclaf | 7-benzyl aminomethyl-8-hydroxy quinolines - bacteriostats and fungistats |
DE3426995A1 (de) | 1984-07-21 | 1986-01-30 | Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart | Halterung einer scheibe, vorzugsweise einer windschutzscheibe |
AU5148696A (en) | 1995-04-08 | 1996-10-30 | Basf Aktiengesellschaft | Synergistic fungicide compositions made of quinoline derivat ives and cytochrom b/c inhibitors |
EP0927164A1 (en) * | 1996-09-10 | 1999-07-07 | PHARMACIA & UPJOHN COMPANY | 8-hydroxy-7-substituted quinolines as anti-viral agents |
MXPA03003263A (es) | 2000-10-12 | 2003-06-06 | Merck & Co Inc | Aza y poliaza naftalenil carboxamidas utiles como inhibidores de la integrasa del virus de inmunodeficiencia humana. |
US6919351B2 (en) | 2000-10-12 | 2005-07-19 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors |
CN1659143A (zh) | 2001-03-01 | 2005-08-24 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的含氮杂芳基化合物 |
DE60322920D1 (de) | 2002-08-13 | 2008-09-25 | Shionogi & Co | Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung |
EP1669348A4 (en) * | 2003-09-30 | 2009-03-11 | Eisai R&D Man Co Ltd | NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND |
FR2889192A1 (fr) * | 2005-07-27 | 2007-02-02 | Cytomics Systems Sa | Composes antifongiques, compositions contenant ces composes et leurs utilisations |
CN101611009A (zh) * | 2006-07-25 | 2009-12-23 | 伊维沃制药股份有限公司 | 喹啉衍生物 |
EP2345642A1 (en) * | 2009-12-29 | 2011-07-20 | Polichem S.A. | Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
EP2345643A1 (en) * | 2009-12-29 | 2011-07-20 | Polichem S.A. | New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
-
2009
- 2009-12-29 EP EP09180895A patent/EP2345641A1/en not_active Withdrawn
-
2010
- 2010-12-28 PT PT107981292T patent/PT2519504E/pt unknown
- 2010-12-28 EP EP10798129.2A patent/EP2519504B1/en active Active
- 2010-12-28 MX MX2012007746A patent/MX2012007746A/es active IP Right Grant
- 2010-12-28 AU AU2010338269A patent/AU2010338269B2/en not_active Ceased
- 2010-12-28 SI SI201030586T patent/SI2519504T1/sl unknown
- 2010-12-28 SG SG2012042305A patent/SG181588A1/en unknown
- 2010-12-28 JP JP2012546434A patent/JP5755245B2/ja not_active Expired - Fee Related
- 2010-12-28 BR BR112012015732A patent/BR112012015732A2/pt not_active IP Right Cessation
- 2010-12-28 ME MEP-2014-36A patent/ME01748B/me unknown
- 2010-12-28 WO PCT/EP2010/070793 patent/WO2011080266A1/en active Application Filing
- 2010-12-28 GE GEAP201012811A patent/GEP20156269B/en unknown
- 2010-12-28 CN CN201080059735.1A patent/CN102712596B/zh not_active Expired - Fee Related
- 2010-12-28 US US13/519,686 patent/US8729076B2/en not_active Expired - Fee Related
- 2010-12-28 DK DK10798129.2T patent/DK2519504T3/da active
- 2010-12-28 PL PL10798129T patent/PL2519504T3/pl unknown
- 2010-12-28 PE PE2012000846A patent/PE20121804A1/es not_active Application Discontinuation
- 2010-12-28 UA UAA201207792A patent/UA109422C2/uk unknown
- 2010-12-28 EA EA201270672A patent/EA020487B1/ru not_active IP Right Cessation
- 2010-12-28 KR KR1020127019423A patent/KR20120097407A/ko not_active Application Discontinuation
- 2010-12-28 CA CA2783230A patent/CA2783230A1/en not_active Abandoned
- 2010-12-28 ES ES10798129.2T patent/ES2460626T3/es active Active
- 2010-12-28 RS RS20140238A patent/RS53303B/en unknown
- 2010-12-28 MY MYPI2012002954A patent/MY162548A/en unknown
- 2010-12-28 NZ NZ600782A patent/NZ600782A/xx not_active IP Right Cessation
-
2012
- 2012-06-11 IL IL220307A patent/IL220307A/en not_active IP Right Cessation
- 2012-06-13 ZA ZA2012/04349A patent/ZA201204349B/en unknown
- 2012-06-15 MA MA34973A patent/MA33830B1/fr unknown
- 2012-06-22 TN TNP2012000319A patent/TN2012000319A1/en unknown
- 2012-06-25 GT GT201200214A patent/GT201200214A/es unknown
- 2012-06-26 CO CO12106820A patent/CO6561775A2/es unknown
- 2012-06-26 CL CL2012001759A patent/CL2012001759A1/es unknown
- 2012-06-27 DO DO2012000185A patent/DOP2012000185A/es unknown
- 2012-06-28 NI NI201200115A patent/NI201200115A/es unknown
- 2012-06-28 EC ECSP12012008 patent/ECSP12012008A/es unknown
-
2013
- 2013-05-06 HK HK13105404.4A patent/HK1178525A1/xx not_active IP Right Cessation
-
2014
- 2014-04-11 HR HRP20140348AT patent/HRP20140348T1/hr unknown
- 2014-05-13 CY CY20141100340T patent/CY1115060T1/el unknown
- 2014-05-21 SM SM201400059T patent/SMT201400059B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
CO6680675A2 (es) | Tidiazoles substituidos y composiciones pesticidas que los contienen | |
ECSP10010722A (es) | Compuestos orgánicos | |
ECSP11011390A (es) | Compuestos espiro-amidas sustituidas | |
CL2011002857A1 (es) | Compuestos derivados de fenil o heteroaril piridina, inhibidores de sintasa de aldosterona; composicion farmaceutica que comprende un compuesto; combinacion farmaceutica que comprende un compuesto; y uso de los compuestos en el tratamiento de enfermedades cardiovasculares. | |
MX336741B (es) | Composiciones farmaceuticas de moduladores de c-met. | |
CR20140106A (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
UY34779A (es) | Anticuerpos anti-il-23 y composiciones farmacéuticas que los contienen | |
ECSP11011340A (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
BR112013007362A2 (pt) | composição farmacêutica | |
CL2012000921A1 (es) | Compuestos derivados de espiropiperidina-metilbenciloxifenil, activadores del receptor rpg-40; composicion farmaceutica que los comprende; y uso del compuesto para tratar diabetes. | |
UY32036A (es) | Derivados de ciclohexil-amida, composiciones farmacéuticas que los contienen, su preparación y aplicaciones | |
EA201101116A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
CL2012003104A1 (es) | Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende. | |
NI201400042A (es) | 2 - tiopirimidinonas | |
HN2009000566A (es) | Nuevos derivados de diosmetina, su procedimiento de prearacion y las composiciones farmaceuticas que lo contienen. | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
UY32704A (es) | Compuestos de 2,3-dihidro-1h-indeno | |
SV2009003429A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
CL2011002258A1 (es) | Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih. | |
UY34166A (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
HN2010001537A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
ECSP099561A (es) | Formulación de nevirapina de liberación prolongada | |
CO7151478A2 (es) | Formulaciones estabilizadas que contienen anticuerpos anti-dll4 | |
UY32520A (es) | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides |